# Polycystic Ovary Syndrome Genetics and Treatment Response

> **NCT01389778** · NA · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin ER
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01389778
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389778, "Polycystic Ovary Syndrome Genetics and Treatment Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01389778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*